ANTI-TENASCIN MONOCLONAL ANTIBODY THERAPY FOR LYMPHOMA

Details for Australian Patent Application No. 2002227175 (hide)

Owner DUKE UNIVERSITY

Inventors ZALUTSKY, Michael; RIZZIERI, David; BIGNER, Darell, D.

Pub. Number AU-A-2002227175

PCT Pub. Number WO2002/051448

Priority 60/257,108 21.12.00 US

Filing date 24 October 2001

Wipo publication date 8 July 2002

International Classifications

A61K 051/10 Preparations containing radioactive substances for use in therapy or testing

C07K 016/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002227175

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002227176

2002227174-SOLE STRUCTURE FOR ELECTROSTATIC DISSIPATIVE FOOTWEAR AND METHOD OF MAKING SAME